Hydrocarbon migration systems analysisVERWEIJ, J. M.Developments in petroleum science. 1993, Vol 35, issn 0376-7361, 276 p.Serial Issue

VLSI reliability in EuropeVERWEIJ, J. F.Proceedings of the IEEE. 1993, Vol 81, Num 5, pp 675-681, issn 0018-9219Article

Matrix metalloproteinase inhibitors : Present achievements and future prospectsDENIS, L. J; VERWEIJ, J.Investigational new drugs. 1997, Vol 15, Num 3, pp 175-185, issn 0167-6997Article

Rational design of new tumoractivated cytotoxic agentsVERWEIJ, J.Oncology. 1999, Vol 57, pp 9-15, issn 0030-2414, SUP1Conference Paper

Application of fluid flow systems analysis to reconstruct the post-Carboniferous hydrogeohistory of the onshore and offshore NetherlandsVERWEIJ, J. M.Marine and petroleum geology. 1999, Vol 16, Num 6, pp 561-579, issn 0264-8172Article

Extraction of kinetic parameters for the chemical vapor deposition of polycrystalline silicon at medium and low pressureHOLLEMAN, J; VERWEIJ, J. F.Journal of the Electrochemical Society. 1993, Vol 140, Num 7, pp 2089-2097, issn 0013-4651Article

Mitomycin CVERWEIJ, J; PINEDO, H. M.Cancer chemotherapy and biological response modifiers annual. 1991, Vol 12, pp 59-65, issn 0921-4410, 7 p.Article

ONE-STEP, HIGH YIELD CONVERSION OF PENICILLIN SULFOXIDES TO DEACETOXYCEPHALOSPORINSDE KONING JJ; KOOREMAN HJ; TAN HS et al.1975; J. ORG. CHEM.; U.S.A.; DA. 1975; VOL. 40; NO 9; PP. 1346-1347; BIBL. 12 REF.Article

Mitomycin C, prototype of a bioreductive alkylating agentVERWEIJ, J; PINEDO, H. M.Chimica oggi. 1991, Vol 9, Num 10, pp 51-55, issn 0392-839XArticle

Estimating regional pore pressure distribution using 3D seismic velocities in the Dutch Central North Sea GrabenWINTHAEGEN, P. L. A; VERWEIJ, J. M.Journal of geochemical exploration. 2003, Vol 78-79, pp 203-207, issn 0375-6742, 5 p.Conference Paper

Adjuvant chemotherapy of soft tissue sarcomasVERWEIJ, J; PINEDO, H. M.Cancer treatment and research. 1997, Vol 91, pp 173-187, issn 0927-3042Article

Adjuvant therapy in primary GIST: state-of-the-artREICHARDT, P; BLAY, J.-Y; LE CESNE, A et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2776-2781, issn 0923-7534, 6 p.Article

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albuminPLOQUIN, A; OLMOS, D; VOEST, E. E et al.British journal of cancer. 2012, Vol 107, Num 7, pp 1025-1030, issn 0007-0920, 6 p.Article

Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursDE JONGE, M. J. A; DUMEZ, H; KITZEN, J. J. E. M et al.European journal of cancer (1990). 2011, Vol 47, Num 9, pp 1328-1335, issn 0959-8049, 8 p.Article

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignanciesHAMBERG, P; STEEGHS, N; LOOS, W. J et al.British journal of cancer. 2010, Vol 102, Num 12, pp 1699-1706, issn 0007-0920, 8 p.Article

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumoursKONINGS, Irhm; DE JONGE, Mja; BURGER, H et al.British journal of cancer. 2010, Vol 103, Num 7, pp 987-992, issn 0007-0920, 6 p.Article

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumoursVAN HERPEN, CMl; ESKENS, FALM; DE JONGE, M et al.British journal of cancer. 2010, Vol 103, Num 9, pp 1362-1368, issn 0007-0920, 7 p.Article

Cytotoxic therapy for the elderly with metastatic breast cancer : A review on safety, pharmacokinetics and efficacyHAMBERG, P; VERWEIJ, J; SEYNAEVE, C et al.European journal of cancer (1990). 2007, Vol 43, Num 10, pp 1514-1528, issn 0959-8049, 15 p.Article

A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumorsFELICI, A; LOOS, W. J; VERWEIJ, J et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 673-680, issn 0344-5704, 8 p.Article

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 with 5-fluorouracil and leucovorin : A safe combinationHOEKSTRA, R; DE VOS, F. Y. F. L; ESKENS, F. A. L. M et al.European journal of cancer (1990). 2006, Vol 42, Num 4, pp 467-472, issn 0959-8049, 6 p.Article

Phase I and pharmacokinetic study of XRI 1576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursDE JONGE, M. J. A; KAYE, S; MISTRY, P et al.British journal of cancer. 2004, Vol 91, Num 8, pp 1459-1465, issn 0007-0920, 7 p.Article

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimensBURGER, H; DEN BAKKER, M. A; STOTER, G et al.European journal of cancer (1990). 2003, Vol 39, Num 6, pp 793-799, issn 0959-8049, 7 p.Article

The use of oral cytotoxic and cytostatic drugs in cancer treatmentSPARREBOOM, A; DE JONGE, M. J. A; VERWEIJ, J et al.European journal of cancer (1990). 2002, Vol 38, Num 1, pp 18-22, issn 0959-8049Article

Farnesyl transferase inhibitors : current developments and future perspectivesESKENS, F. A. L. M; STOTER, G; VERWEIJ, J et al.Cancer treatment reviews. 2000, Vol 26, Num 5, pp 319-332, issn 0305-7372Article

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma : a study of the EORTC early clinical studies group (ECSG)PAVLIDIS, N; AAMDAL, S; WANDERS, J et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 2, pp 167-171, issn 0344-5704Article